3.18 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
PepGen Inc. Common Stock
PEPGNASDAQ • USD
3.19
↗ 0.00 (0.16%)
POST MARKET (AS OF 06:54 PM EDT)
Post Market
AS OF 06:54 PM EDT
3.19
↗ 0.00 (0.16%)
Market: OPEN
PepGen Inc. Common Stock (PEPG) is currently trading at $3.19. PEPG shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, PEPG appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Sep 3, 2026.
Open?$3.18
High?$3.25
Low?$3.10
Prev. Close?$3.18
Volume?514.3K
Avg. Volume?909.5K
VWAP?$3.18
Rel. Volume?0.57x
Bid / Ask
Bid?$3.13 × 100
Ask?$3.27 × 100
Spread?$0.14
Midpoint?$3.20
Valuation & Ratios
Market Cap?220.2M
Shares Out?69.3M
Float?39.8M
Float %?57.5%
P/E Ratio?N/A
P/B Ratio?1.84
EPS?-$1.04
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.
Address
1 MARINA PARK DRIVE, SUITE 900
BOSTON, MA 02210
Phone: 703-456-8000
BOSTON, MA 02210
Phone: 703-456-8000
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?16
Momentum?77
Short Sent.?55
Piotroski F-Score?0/9Weak
Altman Z-Score?1.28Distress
Confidence?45%Low
Short InterestHigh
Short % of Float?11.04%High
Short Interest?4.4M
Days to Cover?3.1
Free Float39.8M
Avg Daily Volume1.4M
Settlement Date2026-08-14
Financial Health
Current Ratio?13.36Strong
Quick Ratio?13.36Strong
Cash Ratio?2.53Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.84CHEAP▾
Peers100
S&P79
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-2.6CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-60.2%WEAK▾
S&P3
ROA?-50.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-69462000
Enterprise Value?$197.5M
Fundamentals ratios updated end of day